Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles
- PMID: 3498440
Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles
Abstract
The HLA-A, B, C, and DR loci of 136 patients with progressive systemic scleroderma have been determined. The patients were classified according to the extent of their skin affection and into groups with or without immunologic and inflammatory signs of the disease. The antigens of the A locus did not show any significant deviations in frequency of occurrence. An increase of HLA-B8 and HLA-DR3 was only proved in the male patient group. Furthermore, in the HLA-DR gene locus, an increase in frequency of HLA-DR1, 2, 3, and 5 could be found. However, in the total set of patients, only the correlation of HLA-DR5 with progressive systemic scleroderma reached significance. Patients suffering from the CREST (calcinosis, Raynaud's phenomenon, esophagus, sclerodactyly, and telangiectasia) syndrome showed an increase of HLA-DR1. Patients with inflammatory signs of the scleroderma showed an accumulation of HLA-DR2. Several HLA-linked genes control the susceptibility to scleroderma.
Similar articles
-
Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5.Dis Markers. 1989 Oct-Dec;7(4):209-13. Dis Markers. 1989. PMID: 2573446
-
HLA-DR antigens in progressive systemic sclerosis (scleroderma).J Rheumatol. 1983 Feb;10(1):128-31. J Rheumatol. 1983. PMID: 6601709
-
Association between DR antigens, rheumatoid arthritis with and without extraarticular features and systemic lupus erythematosus in northern Italy.J Rheumatol. 1988 Jan;15(1):51-3. J Rheumatol. 1988. PMID: 3258384
-
HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease.Lancet. 1988 May 28;1(8596):1185-8. doi: 10.1016/s0140-6736(88)92009-0. Lancet. 1988. PMID: 2897006 Review.
-
HLA and autoimmunity in scleroderma (systemic sclerosis).Int Rev Immunol. 1995;12(2-4):107-28. doi: 10.3109/08830189509056707. Int Rev Immunol. 1995. PMID: 7650416 Review.
Cited by
-
Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort.Arthritis Rheumatol. 2014 Nov;66(11):3170-7. doi: 10.1002/art.38814. Arthritis Rheumatol. 2014. PMID: 25223600 Free PMC article.
-
Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.Ann Rheum Dis. 2000 May;59(5):359-67. doi: 10.1136/ard.59.5.359. Ann Rheum Dis. 2000. PMID: 10784518 Free PMC article.
-
Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.Arthritis Rheumatol. 2016 Nov;68(11):2772-2777. doi: 10.1002/art.39765. Epub 2016 Oct 6. Arthritis Rheumatol. 2016. PMID: 27214100 Free PMC article.
-
Major histocompatibility complex class II genes and systemic sclerosis.Ann Rheum Dis. 1991 Nov;50 Suppl 4(Suppl 4):862-5. doi: 10.1136/ard.50.suppl_4.862. Ann Rheum Dis. 1991. PMID: 1750798 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials